Cargando…
Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients
Breast and uterine cancer are the most frequent female gender related neoplasms whose growth is mostly estrogen dependent. Therefore, any EDC exhibiting estrogenic effects may increase the risk of these two malignancies. This review focuses on the potential role of EDCs with estrogenic potential on...
Autor principal: | Rachoń, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801991/ https://www.ncbi.nlm.nih.gov/pubmed/26831296 http://dx.doi.org/10.1007/s11154-016-9332-9 |
Ejemplares similares
-
GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs)
por: Périan, Séverine, et al.
Publicado: (2020) -
Combined Effects of Different Endocrine-Disrupting Chemicals (EDCs) on Prostate Gland
por: De Falco, Maria, et al.
Publicado: (2021) -
Effects of Endocrine Disrupting Chemicals (EDCs) on Skeletal System Development: A Review
por: J, Chanemougavally, et al.
Publicado: (2023) -
Exposure to endocrine disrupting chemicals (EDCs) and cardiometabolic indices during pregnancy: The HOME Study
por: Vuong, Ann M., et al.
Publicado: (2021) -
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?
por: Autrup, Herman, et al.
Publicado: (2020)